Objective: Although activation of protein kinase C (PKC) modulates the func
tion of normal cardiac myocytes and likely plays a role in the pathogenesis
of cardiomyopathic disease states, the molecular basis of PKC expression i
n human ventricle has not been examined in detail. Methods: We have perform
ed Western analysis and immunohistochemistry on explanted human cardiac tis
sue from nondiseased and diseased specimens using isoform-specific antibodi
es directed against all known PKC isozymes. Results: In homogenates from le
ft and right ventricle, all isoforms except PKC-gamma and theta were detect
ed by immunoblotting, with confirmation using a second antibody directed ag
ainst a different epitope when possible. For PKC-beta II, delta, and epsilo
n, data indicated that these isoforms were variably phosphorylated in vivo,
resulting in multiple bands during immunoblotting. Because of potential an
tibody cross-reactivity, reverse transcriptase polymerase chain reaction (R
T-PCR) was performed which confirmed expression of PKC-alpha, betaI, and ze
ta. Immunohistochemistry demonstrated that all isoforms detected in ventric
ular homogenate by Western analysis could be localized to cardiac myocytes.
From a methodologic standpoint, significant degradation of PKC isoforms co
uld be demonstrated when samples were either frozen or allowed to remain at
room temperature, compared to immediate subcellular fractionation. Conclus
ions: These findings indicate that the PKC expression in human ventricular
myocytes is remarkably diverse, with multiple conventional, novel, and atyp
ical isoforms present, and highlight the importance of sample preparation i
n comparative studies of PKC isoform expression. (C) 2000 Elsevier Science
B.V. All rights reserved.